Anti-HIV effects of IFN-tau in human macrophages: Role of cellular antiviral factors and interleukin-6;Rôles des facteurs antiviraux cellulaires et de l'interleukine-6 dans les propriétés anti-VIH de l'IFN-tau dans des macrophages humains

Pathologie Biologie

Volumn 56, Issue 7-8, 2008, Pages 492-503

  Maneglier, B ^a,b   Rogez Kreuz, C ^c   Dereuddre Bosquet, N ^c   Martal, J ^d   Devillier, P ^a   Dormont, D ^c   Clayette, P ^c  

^a UPRES EA 220   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d INRA Institut National de la Recherche Agronomique   (France)

Author keywords

HIV; IFN; IL 6; Interferon; Macrophages

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYXOVIRUS RESISTANCE PROTEIN A; RIBONUCLEASE L; TAU INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL CULTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PROTEIN SYNTHESIS; SUPERNATANT;

EID: 57049157661     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.06.002     Document Type: Article

References (67)

1. Biron C.A. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin Immunol 10 (1998) 383-390
2. Sareneva T., Julkunen I., and Matikainen S. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immunol 165 (2000) 1933-1938
3. von Hoegen P. Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytes. Immunol Lett 47 (1995) 157-162
4. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu Rev Biochem 67 (1998) 227-264
5. Coccia E.M., Krust B., and Hovanessian A.G. Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J Biol Chem 269 (1994) 23087-23094
6. Poli G., Orenstein J.M., Kinter A., Folks T.M., and Fauci A.S. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science 244 (1989) 575-577
7. Player M.R., Maitra R.K., Silverman R.H., and Torrence P.F. Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense. Antivir Chem Chemother 9 (1998) 225-231
8. Schroder H.C., Kelve M., and Muller W.E. The 2-5A system and HIV infection. Prog Mol Subcell Biol 14 (1994) 176-197
9. Sobol R.W., et al. HIV-1 reverse transcriptase: inhibition by 2′,5′-oligoadenylates. Biochemistry 32 (1993) 12112-12118
10. Adelson M.E., Martinand-Mari C., Iacono K.T., Muto N.F., and Suhadolnik R.J. Inhibition of human immunodeficiency virus (HIV-1) replication in SupT1 cells transduced with an HIV-1 LTR-driven PKR cDNA construct. Eur J Biochem 264 (1999) 806-815
11. Muto N.F., Martinand-Mari C., Adelson M.E., and Suhadolnik R.J. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct. J Virol 73 (1999) 9021-9028
12. Haller O., and Kochs G. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3 (2002) 710-717
13. Gordien E., Rosmorduc O., Peltekian C., Garreau F., Brechot C., and Kremsdorf D. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol 75 (2001) 2684-2691
14. Kochs G., Janzen C., Hohenberg H., and Haller O. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad Sci USA 99 (2002) 3153-3158
15. Liu L., Leaman D.W., Bixby J.A., and Roberts R.M. A type I ovine interferon with limited similarity to IFN-alpha, IFN-omega and IFN-tau: gene structure, biological properties and unusual species specificity. Biochim Biophys Acta 1294 (1996) 55-62
16. Martal J.L., Chene N.M., Huynh L.P., L'Haridon R.M., Reinaud P.B., Guillomot M.W., et al. IFN-tau: a novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities. Biochimie 80 (1998) 755-777
17. Roberts R.M. Interferon-tau and pregnancy. J Interferon Cytokine Res 16 (1996) 271-273
18. Roberts R.M. Interferon-tau, a type 1 interferon involved in maternal recognition of pregnancy. Cytokine Growth Factor Rev 18 (2007) 403-408
19. Martal J., Degryse E., Charpigny G., Assal N., Reinaud P., Charlier M., et al. Evidence for extended maintenance of the corpus luteum by uterine infusion of a recombinant trophoblast alpha-interferon (trophoblastin) in sheep. J Endocrinol 127 (1990) R5-R8
20. Pontzer C.H., Bazer F.W., and Johnson H.M. Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res 51 (1991) 5304-5307
21. Pontzer C.H., Torres B.A., Vallet J.L., Bazer F.W., and Johnson H.M. Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem Biophys Res Commun 152 (1988) 801-807
22. Dereuddre-Bosquet N., Clayette P., Martin M., Mabondzo A., Fretier P., Gras G., et al. Anti-HIV potential of a new interferon, interferon-tau (trophoblastin). J Acquir Immune Defic Syndr Hum Retrovirol 11 (1996) 241-246
23. Soos J.M., Subramaniam P.S., Hobeika A.C., Schiffenbauer J., and Johnson H.M. The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol 155 (1995) 2747-2753
24. Subramaniam P.S., Khan S.A., Pontzer C.H., and Johnson H.M. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Proc Natl Acad Sci USA 92 (1995) 12270-12274
25. Rogez C., Martin M., Dereuddre-Bosquet N., Martal J., Dormont D., and Clayette P. Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines. J Virol 77 (2003) 12914-12920
26. Kedzierska K., Crowe S.M., Turville S., and Cunningham A.L. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev Med Virol 13 (2003) 39-56
27. Soos J.M., Mujtaba M.G., Subramaniam P.S., Streit W.J., and Johnson H.M. Oral feeding of interferon tau can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis. J Neuroimmunol 75 (1997) 43-50
28. Soos J.M., Stuve O., Youssef S., Bravo M., Johnson H.M., Weiner H.L., et al. Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate. J Immunol 169 (2002) 2231-2235
29. Chaouat G., Assal Meliani A., Martal J., Raghupathy R., Elliott J.F., Mosmann T., et al. IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol 154 (1995) 4261-4268
30. Han X., Becker K., Degen H.J., Jablonowski H., and Strohmeyer G. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur J Clin Invest 26 (1996) 286-292
31. Naif H., Ho-Shon M., Chang J., and Cunningham A.L. Molecular mechanisms of IL-4 effect on HIV expression in promonocytic cell lines and primary human monocytes. J Leukoc Biol 56 (1994) 335-339
32. Granowitz E.V., Saget B.M., Wang M.Z., Dinarello C.A., and Skolnik P.R. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol Med 1 (1995) 667-677
33. Kinter A.L., Poli G., Fox L., Hardy E., and Fauci A.S. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 154 (1995) 2448-2459
34. Poli G., et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 172 (1990) 151-158
35. Poli G., Kinter A.L., and Fauci A.S. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 91 (1994) 108-112
36. Wang J., Roderiquez G., Oravecz T., and Norcross M.A. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol 72 (1998) 7642-7647
37. Weissman D., Poli G., and Fauci A.S. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res Hum Retroviruses 10 (1994) 1199-1206
38. Weissman D., Poli G., and Fauci A.S. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J Acquir Immune Defic Syndr Hum Retrovirol 9 (1995) 442-449
39. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., and Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233 (1986) 215-219
40. Maneglier B., Spreux-Varoquaux O., Guillemin G.J., Rogez-Kreuz C., Dormont D., Advenier C., et al. Serotonin modulates HIV replication in primary culture of human macrophages: involvement of 5-HT(1A) sub-type receptors. Pathol Biol (Paris) 55 (2007) 495-503
41. Degryse E., Dietrich M., Nguyen M., Achstetter T., Charlier M., Charpigny G., et al. Addition of a dipeptide spacer significantly improves secretion of ovine trophoblast interferon in yeast. Gene 118 (1992) 47-53
42. Benveniste O., Vaslin B., Villinger F., Le Grand R., Ansari A.A., and Dormont D. Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy. Cytokine 8 (1996) 32-41
43. Schmidtmayerova H., Alfano M., Nuovo G., and Bukrinsky M. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J Virol 72 (1998) 4633-4642
44. Soumelis V., et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98 (2001) 906-912
45. Maneglier B., et al. Comparative effects of two type I interferons, human IFN-alpha and ovine IFN-tau on indoleamine-2,3-dioxygenase in primary cultures of human macrophages. Fundam Clin Pharmacol 21 (2007) 29-34
46. Guillemin G.J., Kerr S.J., and Brew B.J. Involvement of quinolinic acid in AIDS dementia complex. Neurotox Res 7 (2005) 103-123
47. Guillemin G.J., Wang L., and Brew B.J. Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J Neuroinflammation 2 (2005) 16
48. Capuron L., and Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 Suppl. 1 (2003) S119-S124
49. Capuron L., and Miller A.H. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56 (2004) 819-824
50. Capuron L., Ravaud A., Neveu P.J., Miller A.H., Maes M., and Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7 (2002) 468-473
51. Maneglier B., et al. Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT(1A) receptors. Br J Pharmacol 154 1 (2008) 174-182 Epub 2008 Mar 10
52. Bergamini A., et al. HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages. Clin Exp Immunol 112 (1998) 105-111
53. Dereuddre-Bosquet N., et al. Lack of interleukin 10 expression in monocyte-derived macrophages in response to in vitro infection by HIV type 1 isolates. AIDS Res Hum Retroviruses 13 (1997) 961-966
54. Akridge R.E., Oyafuso L.K., and Reed S.G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 153 (1994) 5782-5789
55. Stylianou E., Aukrust P., Kvale D., Muller F., and Froland S.S. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression-down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol 116 (1999) 115-120
56. Finnegan A., Roebuck K.A., Nakai B.E., Gu D.S., Rabbi M.F., Song S., et al. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol 156 (1996) 841-851
57. Cotler S.J., et al. An analysis of acute changes in interleukin-6 levels after treatment of hepatitis C with consensus interferon. J Interferon Cytokine Res 21 (2001) 1011-1019
58. Ito N., et al. Induction of interleukin-6 by interferon alfa and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C. Hepatology 23 (1996) 669-675
59. Zauli G., Re M.C., Gugliotta L., Furlini G., and La Placa M. The elevation of circulating platelets after IFN-alpha therapy in HIV-1 seropositive thrombocytopenic patients correlates with increased plasma levels of IL-6. New Microbiol 16 (1993) 27-34
60. Marfaing-Koka A., et al. In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 11 (1996) 59-68
61. Nakatsuji Y., et al. Beneficial effect of interferon-beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-beta injection. Cytokine 36 (2006) 69-74
62. Gan H.X., Ruef C., Hall B.F., Tobin E., Remold H.G., and Mellors J.W. Interleukin-6 expression in primary macrophages infected with human immunodeficiency virus-1 (HIV-1). AIDS Res Hum Retroviruses 7 (1991) 671-679
63. Baqui A.A., Jabra-Rizk M.A., Kelley J.I., Zhang M., Falkler Jr. W.A., and Meiller T.F. Enhanced interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by LPS stimulated human monocytes isolated from HIV+ patients. Immunopharmacol Immunotoxicol 22 (2000) 401-421
64. Zaitseva M., Lee S., Lapham C., Taffs R., King L., Romantseva T., et al. Interferon gamma and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection. Blood 96 (2000) 3109-3117
65. Bickel M., Dveksler G., Dieffenbach C.W., Ruhl S., Midura S.B., and Pluznik D.H. Induction of interferon-beta and 2′,5′-oligoadenylate synthetase mRNAs by interleukin 6 during differentiation of murine myeloid cells. Cytokine 2 (1990) 238-246
66. Cohen B., Gothelf Y., Vaiman D., Chen L., Revel M., and Chebath J. Interleukin-6 induces the (2′-5′) oligoadenylate synthetase gene in M1 cells through an effect on the interferon-responsive enhancer. Cytokine 3 (1991) 83-91
67. Fujii Y., et al. A potential live vector, foamy virus, directed intra-cellular expression of ovine interferon-tau exhibited the resistance to HIV infection. J Vet Med Sci 66 (2004) 115-121